FI875544L - Anvaendning av 3'-deoxitymidin-2'-en (3'-deoxi-2',3'-didehydrotymidin) foer behandling av patienter infekterade med retrovirus. - Google Patents

Anvaendning av 3'-deoxitymidin-2'-en (3'-deoxi-2',3'-didehydrotymidin) foer behandling av patienter infekterade med retrovirus. Download PDF

Info

Publication number
FI875544L
FI875544L FI875544A FI875544A FI875544L FI 875544 L FI875544 L FI 875544L FI 875544 A FI875544 A FI 875544A FI 875544 A FI875544 A FI 875544A FI 875544 L FI875544 L FI 875544L
Authority
FI
Finland
Prior art keywords
patienter
infekterade
didehydrothymidin
deoxytimidin
deoxi
Prior art date
Application number
FI875544A
Other languages
English (en)
Finnish (fi)
Other versions
FI875544A7 (fi
FI875544A0 (fi
Inventor
Tai-Shun Lin
William H Prusoff
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25478432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI875544(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Yale filed Critical Univ Yale
Publication of FI875544A0 publication Critical patent/FI875544A0/fi
Publication of FI875544A7 publication Critical patent/FI875544A7/fi
Publication of FI875544L publication Critical patent/FI875544L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
FI875544A 1986-12-17 1987-12-16 Anvaendning av 3'-deoxitymidin-2'-en (3'-deoxi-2',3'-didehydrotymidin) foer behandling av patienter infekterade med retrovirus. FI875544L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/942,666 US4978655A (en) 1986-12-17 1986-12-17 Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses

Publications (3)

Publication Number Publication Date
FI875544A0 FI875544A0 (fi) 1987-12-16
FI875544A7 FI875544A7 (fi) 1988-06-18
FI875544L true FI875544L (fi) 1988-06-18

Family

ID=25478432

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875544A FI875544L (fi) 1986-12-17 1987-12-16 Anvaendning av 3'-deoxitymidin-2'-en (3'-deoxi-2',3'-didehydrotymidin) foer behandling av patienter infekterade med retrovirus.

Country Status (22)

Country Link
US (1) US4978655A (cs)
EP (1) EP0273277B1 (cs)
JP (1) JPH07116041B2 (cs)
KR (1) KR960000433B1 (cs)
AT (1) ATE77554T1 (cs)
AU (1) AU593405B2 (cs)
CA (1) CA1293447C (cs)
DE (1) DE3780016T2 (cs)
DK (1) DK174627B1 (cs)
EG (1) EG19157A (cs)
ES (1) ES2038650T3 (cs)
FI (1) FI875544L (cs)
GR (1) GR3005691T3 (cs)
HK (1) HK55896A (cs)
IE (1) IE60866B1 (cs)
IL (1) IL84790A (cs)
LU (1) LU88822I2 (cs)
NL (1) NL960024I2 (cs)
NZ (1) NZ222935A (cs)
PH (1) PH26380A (cs)
PT (1) PT86346B (cs)
ZA (1) ZA877171B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
US6207650B1 (en) 1989-05-15 2001-03-27 Bristol-Myers Squibb Company Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
US5608048A (en) * 1995-06-05 1997-03-04 Bristol-Myers Squibb Company d4 T polymorphic Form 1 process
US5840711A (en) * 1995-06-21 1998-11-24 University Of Kentucky Research Foundation Compositions containing lithium inorganic salts and anti-viral drugs and method of treating viral infections such as acquired immunodeficiency syndrome
CA2189097A1 (en) 1995-11-15 1997-05-16 Pin-Fang Lin Composition and method of treating retroviral infection
US5719132A (en) * 1996-06-27 1998-02-17 Bristol-Myers Squibb Company Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil
WO2000016625A1 (en) * 1998-09-23 2000-03-30 University Of Kentucky Research Foundation Antiviral drug compositions containing lithium inorganic salts
EP1267879A2 (en) * 2000-03-30 2003-01-02 Bristol-Myers Squibb Company Sustained release beadlets containing stavudine
EP2316469A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
JP4980059B2 (ja) 2003-02-19 2012-07-18 エール ユニヴァーシティ 抗ウイルスヌクレオシド類似体およびウイルス感染特にｈｉｖ感染の処置方法
US20040200730A1 (en) * 2003-04-14 2004-10-14 Kyo Jibiki Hydrometallurgical copper recovery process
HRP20110527T1 (hr) 2004-07-27 2011-08-31 Gilead Sciences Nukleozid-fosfonatni konjugati kao sredstva protiv hiv-a
WO2007026156A1 (en) * 2005-08-31 2007-03-08 Cipla Limited Pharmaceutical combinations containing lamivudine, stavudine and nevirapine
EP2818469B1 (en) 2008-12-09 2017-02-15 Gilead Sciences, Inc. Intermediates for the preparation of modulators of toll-like receptors
US20110223131A1 (en) 2010-02-24 2011-09-15 Gilead Sciences, Inc. Antiviral compounds
WO2016001907A1 (en) 2014-07-02 2016-01-07 Prendergast Patrick T Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
TWI806081B (zh) 2014-07-11 2023-06-21 美商基利科學股份有限公司 用於治療HIV之toll樣受體調節劑
JP2018527366A (ja) 2015-09-15 2018-09-20 ギリアード サイエンシーズ， インコーポレイテッド ＨＩＶを処置するためのｔｏｌｌ様レセプターのモジュレーター

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322747A (en) * 1965-04-01 1967-05-30 Merck & Co Inc Thionocarbonate nucleosides
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
JPS5943550B2 (ja) * 1975-08-29 1984-10-23 田辺製薬株式会社 不飽和ヌクレオシドの製法
DE3515870A1 (de) * 1985-05-03 1986-11-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 5-fluortoluol-2,4-disulfochlorid
US4710492A (en) * 1986-06-23 1987-12-01 Yale University 3'-azido-2',3'-dideoxy-5-halouridine and its use in treating patients infected with retroviruses
NL8700089A (nl) * 1987-01-15 1988-08-01 Stichting Rega V Z W Therapeutische toepassing van dideoxythymidine en dideoxythymidineen.
DE3806633A1 (de) * 1987-09-01 1989-03-09 Bayer Ag Antivirales mittel
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物
SE8704298D0 (sv) * 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
JPH0227782A (ja) * 1988-07-15 1990-01-30 Hikari Gijutsu Kenkyu Kaihatsu Kk 半導体発光素子
JPH0438727A (ja) * 1990-06-04 1992-02-07 Sharp Corp 光学式ピックアップ装置の対物レンズ塵埃付着防止機構

Also Published As

Publication number Publication date
KR960000433B1 (ko) 1996-01-06
AU593405B2 (en) 1990-02-08
DE3780016T2 (de) 1992-12-24
ES2038650T3 (es) 1993-08-01
DE3780016D1 (de) 1992-07-30
PT86346B (pt) 1990-11-07
EP0273277A2 (en) 1988-07-06
IE60866B1 (en) 1994-08-24
FI875544A7 (fi) 1988-06-18
IL84790A0 (en) 1988-05-31
FI875544A0 (fi) 1987-12-16
DK557087D0 (da) 1987-10-23
PT86346A (en) 1988-01-01
CA1293447C (en) 1991-12-24
US4978655A (en) 1990-12-18
IL84790A (en) 1993-03-15
EG19157A (en) 1994-09-29
HK55896A (en) 1996-04-03
DK174627B1 (da) 2003-07-28
PH26380A (en) 1992-06-01
ATE77554T1 (de) 1992-07-15
GR3005691T3 (cs) 1993-06-07
AU8090087A (en) 1988-06-23
JPS63215632A (ja) 1988-09-08
NL960024I1 (nl) 1996-12-02
JPH07116041B2 (ja) 1995-12-13
DK557087A (da) 1988-06-18
LU88822I2 (fr) 1997-01-06
EP0273277A3 (en) 1989-09-13
IE873245L (en) 1988-06-17
KR880007079A (ko) 1988-08-26
EP0273277B1 (en) 1992-06-24
NZ222935A (en) 1990-09-26
ZA877171B (en) 1988-03-24
NL960024I2 (nl) 1997-06-02

Similar Documents

Publication Publication Date Title
DE3764686D1 (de) N,n'-dihalo-2-imidazolidinone.
FI874959L (fi) Tvaettmedelskomposition, som innehaoller etylendiamin-n,n'-dibaernstenssyra.
FI873498L (fi) Med en elastisk taetningsprofil foersedd glasskiva, i synnerhet bilglas.
FI873497L (fi) Foer direktlimning avsedd glasskiva, i synnerhet bilglas.
FI870276A7 (fi) Byggelement foer byggserier, i synnerhet foer byggleksaker.
DE3783669D1 (de) Alpha-aryl-alpha-phenethyl-1h-1,2,4-triazol-1-propan-nitrile.
FI875544L (fi) Anvaendning av 3'-deoxitymidin-2'-en (3'-deoxi-2',3'-didehydrotymidin) foer behandling av patienter infekterade med retrovirus.
FI872594A0 (fi) Cementprodukter, vilka innehaoller ytbehandlade oorganiska partiklar.
FI872630L (fi) Farmaceutiska kompositioner foer utvaertes bruk, vilka laett penetrerar huden.
FI875619A0 (fi) 6-benzoxazinyl- och 6-benzotiazonyl-2,3,4,5-tetrahydropyridazin-3-oner.
FI874902A7 (fi) Applikator med behaollare foer applicering av harts- och lackaemnen, isynnerhet nagellack.
FI874428A0 (fi) Foerfarande foer framstaellning av vinylklorid medelst termisk spjaelkning av 1,2-dikloretan.
FI874166L (fi) Anvaendning av 2',3'-dideoxicytidin -2'-en foer behandling av patienter infekterade med retrovirus.
FI872267A0 (fi) Stabila, vattenhaltiga suspensionskoncentratkompositioner.
FI871874A7 (fi) Foerfarande foer framstaellning av 1,4-disubstituerade piperazinderivat.
FI875355L (fi) Foerpackningsbehaollare med oeppningsbar, foerseglingsfoersvagad toppfoerslutning.
FI872815A7 (fi) Luckpanel med foerbaettrad taetningsanordning, saerskilt anvaendbar i kontainertransportfartyg.
FI871637A7 (fi) Foerfarande foer framstaellning av 1,5-benzotiazepinderivat.
FI872598A0 (fi) N-1h-tetrazol-5-yl-2-tiofen-, n-1h -tetrazol-5-yl-2-pyrrol- och n-1h-tetrazol-5-yl-2-furankarboxamider.
FI875362A7 (fi) Foerfarande foer framstaellning av n,n'-disubstituerade karbamider.
FI874413L (fi) Foerfarande foer framstaellning av aralkyl-4h-1,2,4-triazolderivat.
FI874956A7 (fi) Ettstegsfoerfarande foer framstaellning av blandsubstituerade 1,2-diacyl-sn-glycero-3-fosfokoliner.
FI871368L (fi) Foerfarande foer framstaellning av 2,3,4,5-tetrafluor-bensoylacetater.
FI874085L (fi) Foerfarande foer framstaellning av 2,3,5,6-tetraklorpyridin.
FI865279A0 (fi) Profilbelagd foensterkonstruktion, i synnerhet foer bandfoenster.

Legal Events

Date Code Title Description
BB Publication of examined application
FD Application lapsed

Owner name: YALE UNIVERSITY